Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study

Camille Maringe, James Spicer, Melanie Morris et al. · The Lancet Oncology · 2020 · 1.9K citations · Full text

Medicine, Health Sciences, Population Health Sciences +14

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients

Angela George, Daniel Riddell, Sheila Seal et al. · Scientific Reports · 2016 · 224 citations · Full text

Medicine, Genetics, Oncology +17

Evaluation of Cancer-Based Criteria for Use in Mainstream<i>BRCA1</i>and<i>BRCA2</i>Genetic Testing in Patients With Breast Cancer

Zoe Kemp, Alice Turnbull, Shawn Yost et al. · JAMA Network Open · 2019 · 115 citations · Full text

Medicine, Genetics, Oncology +15

Pathology update to the Manchester Scoring System based on testing in over 4000 families

D. Gareth Evans, Elaine F. Harkness, Inga Plaskocinska et al. · Journal of Medical Genetics · 2017 · 66 citations · Full text

Medicine, Oncology, Pathology +10

Mainstreamed genetic testing for women with ovarian cancer: first-year experience

Belinda Rahman, Anne Lanceley, Rebecca Kristeleit et al. · Journal of Medical Genetics · 2018 · 55 citations · Full text

Medicine, Genetics, Oncology +12